{
    "eid": "2-s2.0-85149979449",
    "title": "Proenkephalin as a Novel Prognostic Marker in Heart Failure Patients: A Systematic Review and Meta-Analysis",
    "cover-date": "2023-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Catalysis",
            "@code": "1503",
            "@abbrev": "CENG"
        },
        {
            "@_fa": "true",
            "$": "Molecular Biology",
            "@code": "1312",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Spectroscopy",
            "@code": "1607",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Computer Science Applications",
            "@code": "1706",
            "@abbrev": "COMP"
        },
        {
            "@_fa": "true",
            "$": "Physical and Theoretical Chemistry",
            "@code": "1606",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Organic Chemistry",
            "@code": "1605",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Inorganic Chemistry",
            "@code": "1604",
            "@abbrev": "CHEM"
        }
    ],
    "keywords": [
        "heart failure",
        "mortality",
        "proenkephalin",
        "prognostic marker",
        "rehospitalization"
    ],
    "authors": [
        "Noppachai Siranart",
        "Khamik Laohasurayotin",
        "Tanattida Phanthong",
        "Walit Sowalertrat",
        "Aekarach Ariyachaipanich",
        "Ronpichai Chokesuwattanaskul"
    ],
    "citedby-count": 1,
    "ref-count": 30,
    "ref-list": [
        "Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017",
        "Epidemiology of heart failure",
        "Forecasting the impact of heart failure in the United States: A policy statement from the American Heart Association",
        "The Acute Decompensated Heart Failure National Registry (ADHERE): Opportunities to improve care of patients hospitalized with acute decompensated heart failure",
        "Proenkephalin and prognosis in heart failure with preserved ejection fraction: A GREAT network study",
        "Effect of Natriuretic Peptide\u2013Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients with Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial",
        "Proenkephalin, Renal Dysfunction, and Prognosis in Patients with Acute Heart Failure: A GREAT Network Study",
        "Prognostic Usefulness of Proenkephalin in Stable Ambulatory Patients with Heart Failure",
        "Clinical Correlates and Prognostic Value of Proenkephalin in Acute and Chronic Heart Failure",
        "Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure",
        "Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting",
        "Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses",
        "Are healthcare workers\u2019 intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review",
        "Meta-analysis in clinical trials",
        "Measuring inconsistency in meta-analyses",
        "Publication bias in clinical research",
        "Analysing data and undertaking meta-analyses",
        "Proenkephalin in Heart Failure",
        "Proenkephalin: A New Biomarker for Glomerular Filtration Rate and Acute Kidney Injury",
        "Endogenous Cardiac Opioids: Enkephalins in Adaptation and Protection of the Heart",
        "Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress?",
        "Oxidative stress induces proorphanin FQ and proenkephalin gene expression in astrocytes through p38- and ERK-MAP kinases and NF-kappaB",
        "Urine N-terminal pro-B-type natriuretic peptide and plasma proenkephalin are promising biomarkers for early diagnosis of cardiorenal syndrome type 1 in acute decompensated heart failure: A prospective, double-center, observational study in real-world",
        "2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure",
        "Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial",
        "Analytical performance of an immunoassay to measure proenkephalin",
        "Proenkephalin and prognosis after acute myocardial infarction",
        "Cardiorenal syndrome\u2014Current understanding and future perspectives",
        "Connecting heart failure with preserved ejection fraction and renal dysfunction: The role of endothelial dysfunction and inflammation",
        "Neprilysin inhibition does not alter dynamic of proenkephalin-A 119-159 and pro-substance P in heart failure"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}